Home

Treatment

Read time: 4 min

Congress highlights

Educating the patient aids effective treatment of migraine

Teaching the patient about their brain can truly make a difference in their engagement with...

Read time: 3 min

Congress highlights

Why is migraine the second most disabling disease worldwide?

Migraine affects all areas of life. Its sudden unpredictable onset with severe incapacitating...

Read time: 4 min

Congress highlights

Why is migraine not just a bad headache?

Recurrent incapacitating headaches accompanied by disorienting neurological symptoms prevents the...

Read time: 3 min

Congress highlights

Is chronic migraine a more chronic severe episodic migraine?

Migraine-associated genes, activation of specific brain regions and cervical nerves, and...

Read time: 3 min

Congress highlights

Do men and women experience psychiatric disorders differently?

There are several known epidemiological differences between the genders in psychiatric disorders....

Read time: 3 min

Congress highlights

Distinguishing comorbidities from differential diagnoses in bipolar disorder

Making a diagnosis of bipolar disorder (BD) can be challenging — comorbid psychiatric...

Read time: 2 min

Social and cognitive interventions that improve outcomes for patients with psychosis

A 3-month critical time intervention service involving social workers and peer specialists to...

Read time: 3 min

Congress highlights

In the shadow of mania: Cognitive impairment and depression in bipolar disorder

Although manic or hypomanic episodes are the defining features of bipolar disorder (BD), depressive...

Read time: 3 min

Congress highlights

Early effects of antidepressants – a clue to mechanism of action

The delay in onset of effect of antidepressant treatment can be frustrating both for the patient...

Depression, Bipolar

Read time: 3 min

Congress highlights

Inflammatory biomarkers in mood disorders and implications for treatment

Inflammation appears to play a role in the development of major depressive disorder (MDD) and...

Parkinson's Disease

Read time: 3 min

Congress highlights

Is there a role for neuroinflammation in the pathogenesis of Parkinson’s disease?

During a plenary session at EAN 2019 on the role of inflammation in “non-inflammatory”...

Depression, Schizophrenia

Read time: 3 min

Congress highlights

Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia

Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country